| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | $87.9K | $5.86 | Jun 24, 2024 | Direct |
| Minerva Neurosciences, Inc. | Director | Stock Option (right to buy) | 12.5K | Sep 27, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GANX | Gain Therapeutics, Inc. | Jun 24, 2024 | 1 | $0 | 4 | Jun 26, 2024 | Director |
| NERV | Minerva Neurosciences, Inc. | Sep 27, 2023 | 1 | $0 | 4 | Sep 29, 2023 | Director |
| GANX | Gain Therapeutics, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
| GANX | Gain Therapeutics, Inc. | Sep 20, 2022 | 1 | $0 | 4 | Sep 22, 2022 | Director |
| NERV | Minerva Neurosciences, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
| NERV | Minerva Neurosciences, Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |